Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes.
Home PD, Bolli GB, Mathieu C, Deerochanawong C, Landgraf W, Candelas C, Pilorget V, Dain MP, Riddle MC. Home PD, et al. Among authors: landgraf w. Diabetes Obes Metab. 2015 Jan;17(1):15-22. doi: 10.1111/dom.12329. Epub 2014 Jul 12. Diabetes Obes Metab. 2015. PMID: 24957785 Free PMC article. Clinical Trial.
Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: a pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials.
Owens DR, Traylor L, Dain MP, Landgraf W. Owens DR, et al. Among authors: landgraf w. Diabetes Res Clin Pract. 2014 Nov;106(2):264-74. doi: 10.1016/j.diabres.2014.08.003. Epub 2014 Aug 12. Diabetes Res Clin Pract. 2014. PMID: 25195151 Free article.
Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study.
Aschner P, Sethi B, Gomez-Peralta F, Landgraf W, Loizeau V, Dain MP, Pilorget V, Comlekci A. Aschner P, et al. Among authors: landgraf w. J Diabetes Complications. 2015 Aug;29(6):838-45. doi: 10.1016/j.jdiacomp.2015.04.003. Epub 2015 Apr 11. J Diabetes Complications. 2015. PMID: 25981123 Free article. Clinical Trial.
Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes.
Owens DR, Bolli GB, Charbonnel B, Haak T, Landgraf W, Porcellati F, Traylor L, Kautzky-Willer A. Owens DR, et al. Among authors: landgraf w. Diabetes Obes Metab. 2017 Nov;19(11):1546-1554. doi: 10.1111/dom.12966. Epub 2017 Jul 27. Diabetes Obes Metab. 2017. PMID: 28449412
The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL.
Hanefeld M, Traylor L, Gao L, Landgraf W. Hanefeld M, et al. Among authors: landgraf w. Cardiovasc Diabetol. 2017 May 19;16(1):66. doi: 10.1186/s12933-017-0548-0. Cardiovasc Diabetol. 2017. PMID: 28526014 Free PMC article.
63 results